S&P 500 (NYSE:SPY) component CR Bard (NYSE:BCR) will unveil its latest earnings tomorrow, Thursday, January 31, 2013. C.R. Bard designs, makes, and sells diagnostic, medical, surgical, and patient care devices.
CR Bard Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for net income of $1.67 per share, a decline of 1.8% from the company’s actual earnings for the same quarter a year ago. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged. It also has not changed during the last month. Analysts are projecting profit to rise by 2.2% compared to last year’s $6.54.
Last quarter, the company came in at profit of $1.64 per share against a mean estimate of net income of $1.63 per share, beating estimates after missing them in the previous quarter. In the second quarter, it missed forecasts by 2 cents.
Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Click here for our fresh Feature Stock Pick now!
Analyst Ratings: There are mostly holds on the stock with 10 of 18 analysts surveyed giving that rating.
Wall St. Revenue Expectations: Analysts are projecting a rise of 0.7% in revenue from the year-earlier quarter to $757.5 million.
A Look Back: In the third quarter, profit fell 0.6% to $129.3 million ($1.50 a share) from $130.1 million ($1.46 a share) the year earlier, but exceeded analyst expectations. Revenue rose 0.5% to $722.9 million from $719.2 million.
Here’s how CR Bard traded following its last earnings report 3 months ago and leading up to its upcoming earnings report this week: